TY - JOUR
T1 - Self-Immolative Fluorescent and Raman Probe for Real-Time Imaging and Quantification of γ-Glutamyl Transpeptidase in Living Cells.
AU - Zhang, Yang
AU - Zhang, Gengwu
AU - Yang, Peng
AU - Moosa, Basem
AU - Khashab, Niveen M.
N1 - KAUST Repository Item: Exported on 2020-10-01
Acknowledgements: We thank King Abdulaziz City for Science and Technology (KACST) for its generous funding through the MERS-CoV research grant program (number 20-0004), which is a part of the Targeted Research Program (TRP).
PY - 2019/7/24
Y1 - 2019/7/24
N2 - Characterizing over-expressed enzymes or biomarkers in living cells is critical for the molecular understanding of disease pathology and consequently for designing precision medicines. Herein, a “switch-on” probe is designed to selectively detect γ-glutamyl transpeptidase (GGT) in living cells via a unique ensemble of enhanced fluorescence and surface-enhanced Raman scattering (SERS). In the presence of GGT, the γ-glutamyl bond in the probe molecule is cleaved, thereby activating a fluorescent probe molecule as well as a Raman reporter molecule. Consequently, the detection of GGT is achieved based on both plasmonic fluorescent enhancement and SERS with a detection limit as low as 1.2 × 10–3 U/L (normal range for GGT levels in the blood is 9–48 U/L). The main advantage of this platform is that on the occasion of fluorescence signal interference, especially in the presence of free metal ions in cells, the SERS signals still hold high stability as a backup. This work highlights the benefits of the marriage of two complimentary sensing techniques into one platform that can overcome the major obstacles of detection of real-time biomarkers and imaging in living cells.
AB - Characterizing over-expressed enzymes or biomarkers in living cells is critical for the molecular understanding of disease pathology and consequently for designing precision medicines. Herein, a “switch-on” probe is designed to selectively detect γ-glutamyl transpeptidase (GGT) in living cells via a unique ensemble of enhanced fluorescence and surface-enhanced Raman scattering (SERS). In the presence of GGT, the γ-glutamyl bond in the probe molecule is cleaved, thereby activating a fluorescent probe molecule as well as a Raman reporter molecule. Consequently, the detection of GGT is achieved based on both plasmonic fluorescent enhancement and SERS with a detection limit as low as 1.2 × 10–3 U/L (normal range for GGT levels in the blood is 9–48 U/L). The main advantage of this platform is that on the occasion of fluorescence signal interference, especially in the presence of free metal ions in cells, the SERS signals still hold high stability as a backup. This work highlights the benefits of the marriage of two complimentary sensing techniques into one platform that can overcome the major obstacles of detection of real-time biomarkers and imaging in living cells.
UR - http://hdl.handle.net/10754/656450
UR - http://pubs.acs.org/doi/10.1021/acsami.9b07186
UR - http://www.scopus.com/inward/record.url?scp=85071062154&partnerID=8YFLogxK
U2 - 10.1021/acsami.9b07186
DO - 10.1021/acsami.9b07186
M3 - Article
C2 - 31290645
SN - 1944-8244
VL - 11
SP - 27529
EP - 27535
JO - ACS Applied Materials & Interfaces
JF - ACS Applied Materials & Interfaces
IS - 31
ER -